Clinical Use of Carotid Intima-Media Thickness: Review of the Literature

R. Todd Hurst; Daniel W.C. Ng; Chris Kendall; Bijoy Khandheria

doi:10.1016/j.echo.2007.02.028

Clinical Use of Carotid Intima-Media Thickness: Review of the Literature

R. Todd Hurst, Daniel W.C. Ng, Chris Kendall, Bijoy Khandheria

Cardiovascular Diseases

Research output: Contribution to journal › Review article › peer-review

81 Scopus citations

Abstract

Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.

Original language	English (US)
Pages (from-to)	907-914
Number of pages	8
Journal	Journal of the American Society of Echocardiography
Volume	20
Issue number	7
DOIs	https://doi.org/10.1016/j.echo.2007.02.028
State	Published - Jul 2007

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.echo.2007.02.028

Cite this

@article{dd21e29a7544469ba4d5dae5119a2212,

title = "Clinical Use of Carotid Intima-Media Thickness: Review of the Literature",

abstract = "Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.",

author = "Hurst, {R. Todd} and Ng, {Daniel W.C.} and Chris Kendall and Bijoy Khandheria",

year = "2007",

month = jul,

doi = "10.1016/j.echo.2007.02.028",

language = "English (US)",

volume = "20",

pages = "907--914",

journal = "Journal of the American Society of Echocardiography",

issn = "0894-7317",

publisher = "Mosby Inc.",

number = "7",

}

TY - JOUR

T1 - Clinical Use of Carotid Intima-Media Thickness

T2 - Review of the Literature

AU - Hurst, R. Todd

AU - Ng, Daniel W.C.

AU - Kendall, Chris

AU - Khandheria, Bijoy

PY - 2007/7

Y1 - 2007/7

N2 - Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.

AB - Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.

UR - http://www.scopus.com/inward/record.url?scp=34347355523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347355523&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2007.02.028

DO - 10.1016/j.echo.2007.02.028

M3 - Review article

C2 - 17617324

AN - SCOPUS:34347355523

SN - 0894-7317

VL - 20

SP - 907

EP - 914

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

IS - 7

ER -

Clinical Use of Carotid Intima-Media Thickness: Review of the Literature

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this